FDA Office Of Criminal Investigations Overhaul May Follow Director’s Exit
This article was originally published in The Gray Sheet
Executive Summary
The resignation of Terry Vermillion, the long-time head of FDA’s Office of Criminal Investigations, will give the agency a chance to thoroughly overhaul the office.